Inify Laboratories AB — AGM Information 2024

Nov 15, 2024

The English text is an unofficial translation of the notice to the Extraordinary General Meeting Inify Laboratories AB (publ), originally drafted in Swedish. In case of any discrepancies between the Swedish original and this translation, the Swedish version shall prevail.

Notice to Extraordinary General Meeting in Inify Laboratories AB (publ)

The shareholders of Inify Laboratories AB (publ), corporate registration number 559345-4431 ("Inify" or "the Company"), are hereby invited to attend the Extraordinary General Meeting on December 6th , 2024 at 10 am CET at Inify Laboratories AB's office, Scheeles väg 3, 171 65 Solna.

Right to participate and notification

Shareholders who wish to participate in the Extraordinary General Meeting with the right to vote shall be entered in the share register kept by Euroclear Sweden AB as of November 28th , 2024.

Shareholders who wish to participate in the Extraordinary General Meeting must also give notice of attendance by e-mail to ir@inify.com by December 2nd , 2024 at the latest.

Nominee registered shares

A shareholder who has its shares registered with a nominee must, in order to be entitled to participate in the general meeting, have the shares registered in its own name through the nominee, so that the shareholder is registered in the share register kept by Euroclear Sweden AB on the record date of November 28th, 2024. Such registration may be temporary (so-called voting rights registration). Shareholders who wish to register the shares in their own name must, in accordance with the respective nominee's routines, request that the nominee make such voting rights registration. Registration of voting rights that have been requested by shareholders at such a time that the registration has been made by the relevant nominee no later than December 2nd, 2024 will be taken into account when preparing the register of shareholders.

Particular for shareholders registered at Norska Verdipapirsentralen (VPS)

• Shareholders registered at Norska Verdipapirsentralen (VPS) who are not registered at Euroclear Sweden AB, Sweden, and wish to be entitled to vote at the Extraordinary General Meeting must give notice of attendance to DNB Bank ASA at the latest on November 21st , 2024, at 12:00 (noon) local time. The notice of attendance is made on a specific application form that is available on the Company's website and, upon request, will be sent by post to shareholders who so wish. The notice of attendance shall be sent to DNB Bank ASA, Verdipapirservice, PB 1600 Sentrum, N-0021 Oslo, or by e-mail to vote@dnb.no.
• DNB Bank ASA will temporarily record the shares at Euroclear Sweden AB in the name of the shareholder. Shareholders recorded at VPS must also, as described above, give notice of attendance to the Company in order to obtain the right to vote at the extraordinary general meeting.

Proposed agenda

• 1. Opening of the meeting
• 1. Election of a chairman of the meeting
• 1. Preparation and approval of the voting list
• 1. Approval of the agenda
• 1. Election of one or two persons to approve the minutes of the meeting.
• 1. Determination of whether the meeting was duly convened
• 1. Resolutions:
  2. o On authorization for the board to resolve on share issues
• 1. Closing of the meeting

Resolution on authorization (Item 7)

The Board of Director proposes that the extraordinary general meeting resolves to authorize the board of directors to resolve on share issues in accordance with Attachment 1.

Inify Laboratories AB Scheeles väg 3 171 65 Solna, Sweden www.inify.com

The number of shares and votes

The number of outstanding votes in the Company at the time of this notice amounts to a total of 45,236,750 divided into a total of 45,236,750 shares. The Company holds no own shares.

Personal data

For information on how your personal data is processed, please see https://www.euroclear.com/dam/ESw/Legal/Privacy-notice-bolagsstammor-engelska.pdf

Solna in November 2024 Inify Laboratories AB (publ) The Board of Directors

Attachment 1

PROPOSAL BY THE BOARD OF DIRECTORS OF INIFY LABORATORIES AB REGARDING AUTHORIZATION TO RESOLVE ON SHARE ISSUES

The Board of Directors of INIFY Laboratories AB, reg. no. 559345-4431 (the "Company"), proposes that the Extraordinary General Meeting authorizes the Board of Directors to, for the period until the next Annual General Meeting, on one or more occasions, resolve on share issues.

Shares may be issued with or without preferential rights for the Company's shareholders and may be made with or without provision for contribution in kind, set-off or other conditions. The purpose of the authorization is to be able to carry out the directed share issue and the subsequent repair issue that the Company intends to carry out and which was announced by the Company on November 15, 2024. The total number of shares that may be issued pursuant to the authorization shall not be limited in any other way than what follows from the limitations of the share capital and the number of shares in the Articles of Association at any given time.

The Board of Directors or a person appointed by the Board of Directors is authorized to make minor adjustments required for the registration of the resolution with the Swedish Companies Registration Office. Resolutions in accordance with the above require the support of at least two-thirds of both the votes cast and the shares represented at the extraordinary general meeting.

_____________

Stockholm, November 2024 INIFY Laboratories AB The Board of Directors

Anmälan om registrering inför extra bolagsstämma i Inify Laboratories AB (publ) den 6 december, 2024 / Application for registration before the Extraordinary General Meeting in Inify Laboratories AB (publ) on December 6, 2024

Aktieägare i Inify Laboratories AB (publ) noterade hos VPS Norge skall ha inkommit med anmälan om rösträttsregistrering enligt nedan senast den 21 november 2024 kl 12.00 lokal tid. Shareholders of Inify Laboratories AB (publ) registered with VPS Norway must apply for registration for voting purposes according to below by November 21, 2024, at 12:00 hours (noon) CET.

Returneras via e-post eller brev/To be returned by e-mail or mail E-mail address: vote@dnb.no Adress/Address: DNB Bank ASA, Verdipapirservice, PB 1600 Sentrum, 0021 Oslo, Norway

Antal aktier / Number of shares:

Telefonnummer under dagtid / Telephone No. Daytime:

Ort och datum / Place and Date:

Aktieägarens namnteckning (vid firmateckning, bifoga registreringsbevis) / Authorized signature (where a company signature, please enclose list of authorized signatures):

Namnförtydligande / Name in block letters:

☐Deltar personligen i stämman / Will attend in person

☐Företräds vid årsstämman genom ombud enligt nedanstående eller separat fullmakt / Represented at the Extraordinary General Meeting by proxy holder as per details below or separate proxy

Fullmakt för (Observera att fullmakten måste dateras och undertecknas) / Proxy for (The proxy must be dated and signed):

Ombudets namn / Name of proxy holder:

Utdelningsadress / Address:

Postnummer och ortnamn / Zip code and city:

Telefonnummer / Telephone No:

att vid den extra bolagsstämman i Inify Laboratories AB (publ), org.nr 559345-4431, den 6 december 2024 och eventuell dag för fortsatt bolagsstämma företräda mig/oss och rösta för samtliga mina/våra aktier i bolaget. / as a proxy to represent me/us and to vote for all my/our shares in Inify Laboratories AB (publ), corporate registration no. 559345-4431, at the Extraordinary General Meeting on December 6, 2024, and, as the case may be, on any day for a continued shareholders' meeting.

Inify Laboratories AB Scheeles väg 3 171 65 Solna, Sweden www.inify.com